Vistagen Therapeutics, Inc. (VTGN) SEC Filings — 2025
16 SEC filings for Vistagen Therapeutics, Inc. (VTGN) in 2025.
Filings
- Vistagen Therapeutics, Inc. 8-K Filing — 8-K · Dec 22, 2025
- Vistagen Therapeutics Files 8-K: Director/Officer Changes & More — 8-K · Dec 3, 2025
- Vistagen Therapeutics Files 8-K on Financials — 8-K · Nov 13, 2025
- Vistagen Therapeutics, Inc. 8-K Filing — 8-K · Nov 4, 2025
- Vistagen Therapeutics Files 8-K on Officer/Director Changes — 8-K · Oct 29, 2025
- Vistagen Therapeutics Files 8-K on Officer/Director Changes — 8-K · Sep 15, 2025
- Vistagen Relies on Capital Raises Amidst Zero Revenue — 10-Q · Aug 7, 2025
- Vistagen's Executive Pay Leans Heavily on Equity Incentives — DEF 14A · Jul 28, 2025
- Vistagen Therapeutics Files 8-K on Leadership Changes — 8-K · Jun 25, 2025
- Vistagen Therapeutics, Inc. 10-K Filing — 10-K · Jun 17, 2025
- Vistagen Therapeutics Files 8-K — 8-K · Jun 2, 2025
- Vistagen Therapeutics Files 8-K — 8-K · Mar 6, 2025
- Vistagen Therapeutics Files 10-Q for Q3 2024 — 10-Q · Feb 13, 2025
- Vistagen Therapeutics Files 8-K — 8-K · Feb 5, 2025
- Vistagen Therapeutics Files 8-K — 8-K · Jan 14, 2025
- Vistagen Therapeutics Files 8-K — 8-K · Jan 13, 2025